Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2022-02-14 Regulatory Filings
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a sales agreement between PharmaCielo and Greenstein for supplying THC products in Germany. It contains no financial statements, no regulatory filings, no management or board changes, no voting results, no audit information, no earnings data, and no detailed financial or strategic presentations. It is a corporate announcement about a commercial agreement and future business plans. The document length is 8972 characters, which is substantial but the content is clearly a news announcement rather than a report or regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other categories.
2022-02-14 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release providing an update on PharmaCielo's sales progress in Latin America and details about a non-brokered private placement of debenture units. It includes management commentary, descriptions of ongoing business activities, and financing details related to the issuance of debenture units. There are no comprehensive financial statements or detailed financial performance data typical of an Annual Report (10-K) or Interim Report (IR). The document is not a transcript, audit report, or regulatory filing in the strict sense, but rather a capital/financing update combined with operational progress information. The key focus on the issuance of debenture units and financing terms aligns best with the Capital/Financing Update category (CAP).
2022-02-04 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 90% confidence The document text is mostly corrupted or contains non-readable characters and images intentionally omitted. There is no clear textual content indicating any specific report type such as Annual Report, Earnings Release, or Management Discussion. The text does not contain any clear financial data, regulatory body references, or report titles. Given the lack of substantive readable content and the presence of placeholders for images, this document appears to be a regulatory filing or miscellaneous filing that does not fit into other categories. Therefore, the best classification is Regulatory Filings (RNS).
2022-01-05 English
Material change report - English.pdf
Capital/Financing Update Classification · 100% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change event dated December 31, 2021. It describes the closing of an initial tranche of a private placement of debenture units, including terms of the offering, participation by insiders, and regulatory disclosures under Canadian securities laws (MI 61-101). The document is a regulatory filing reporting a material change event related to financing activities, specifically a private placement. It is not a full financial report, earnings release, or management discussion, but a formal notification of a material financing transaction. Therefore, the document fits best under the category 'Capital/Financing Update (CAP)'. The document length (12,687 characters) and detailed content confirm it is the report itself, not just an announcement or certification.
2022-01-05 English
News release - English.pdf
Regulatory Filings
2021-12-31 English
News release - English.pdf
Regulatory Filings
2021-12-22 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.